Tecentriq (Atezolizumab)

Tecentriq is a type of immunotherapy that blocks certain proteins and enables your immune system to better locate and fight cancerous cells. 

Is Tecentriq (Atezolizumab) Immunotherapy?

A type of immunotherapy treatment, Tecentriq is a medication used to treat certain cancers, including mesothelioma. Also known as atezolizumab, this medication can be taken alone or in conjunction with other treatments and drugs. Immunotherapy treatment focuses on targeting specific elements instead of chemotherapy or radiation, which kills both cancerous and healthy cells simultaneously. Immunotherapies can stimulate your immune system to fight off cancer cells more efficiently, enabling white blood cells in your immune system to better target and fight harmful cells that aren’t supposed to be there.

How This Immunotherapy Treatment Works

The way this drug helps fight cancer is by blocking the PD-L1 protein in cancer cells. This helps because T cells are white blood cells that attack cells lacking in PD-L1. Once blocked, the immune system can better recognize and fight tumors. This medication is generally used in conjunction with other treatments like chemotherapy, radiation, or surgery.

Mesothelioma and Tecentriq

Since Tecentriq works to block PD-L1 receptors from cancerous cells, it’s been applied to mesothelioma patients, specifically pleural mesothelioma, cancer that affects the lining of the lungs. Since this medication has a reasonable success rate in patients with lung cancer, it was thought that the drug would assist with mesothelioma as well.

Connect with a Top Mesothelioma Doctor and Specialist

What Are the Side Effects of Tecentriq

All medications come with some risk for side effects. A specialist will be able to give you specifics. The most common side effects in patients who have been given Tecentriq include:

  • Alopecia (Hair loss)
  • Constipation
  • Diarrhea
  • Lack of appetite
  • Fatigue
  • Nausea

More rare and adverse reactions can include:

  • Colitis
  • Hepatitis
  • Hyperthyroidism
  • Hypothyroidism
  • Pneumonitis
  • Rash

Tecentriq is not advised for pregnant women or women who are breastfeeding. More rarely, there have been adverse reactions regarding fertility in women of that age group. Also make sure to tell your doctor if you take any other medications, vitamins, or herbal supplements.

If you experience any side effects, give your medical center a call immediately. They may be able to prescribe you something that can help take the edge off. Make sure you also follow your doctor’s dose recommendations for the best outcome.

Clinical Trials with Tecentriq

Researchers tested out this medication in clinical trials before it gained popularity with medical professionals for fighting mesothelioma. Clinical trials are research studies involving people that allow them to test out new drugs. Some clinical trials are free, some pay patients to participate, and others charge.

The National Cancer Institute has a comprehensive list of clinical trials offered around the US for all kinds of emerging medications. Be careful where you’re researching and selecting your clinical trials though, as some have been scams. The National Cancer Institute is a reliable and legitimate source for trials that patients can access. They even have a current clinical trial using Tecentriq (atezolizumab) in patients with Stages 1, 2, and 3 of malignant pleural mesothelioma that is being held in 176 locations. Clinical trials can be helpful because they offer alternative treatment options to patients. Always consult with a doctor first, however, to see if a clinical trial is right for you.

Talk to Your Doctor About Tecentriq

Once diagnosed with mesothelioma, your doctor will develop a treatment plan for you. This plan differs with each patient and is based on the overall health, mesothelioma stage, and site. If immunotherapy and Tecentriq seem like treatment options you want to consider, mention it to your doctor, they’ll be able to tell you if its the right fit.

Author Jennifer Verta

Jennifer Verta thrives as a digital content writer at Mesothelioma Hub. She has been producing content for clients since before she graduated from the University of Colorado at Denver with a Bachelor of Arts in Communication and a Minor in English Writing. Jen’s mission is to help promote awareness of mesothelioma to as many people as possible by providing only the most up-to-date and accurate content available. When she isn’t cranking the gears at work, Jen can be found snowboarding, hiking, catching live music, or socializing with friends.

Sources

Broderick, J. (2018). Tecentriq Granted Priority Review to Treat Lung Cancer. Retrieved from February 25th, 2020 from https://www.curetoday.com/articles/tecentriq-granted-priority-review-to-treat-lung-cancer

DailyMed. (2019). Drug Label Information. Retrieved from February 25th, 2020 from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6fa682c9-a312-4932-9831-f286908660ee&audience=consumer

National Cancer Institute. Clinical Trials Using Atezolizumab. Retrieved from February 25th, 2020 from https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/atezolizumab

Tecentriq. (2020) Connect with Purpose. Retrieved from February 25th, 2020 from https://www.tecentriq-hcp.com/

WebMD. (2020). Immunotherapy Treatment for Mesothelioma. Retrieved from February 25th, 2020 from https://www.webmd.com/lung-cancer/mesothelioma-immunotherapy#1